English Chinese (Simplified) Danish German Greek Icelandic Italian Japanese Korean Russian Spanish Vietnamese
    You are here:
  • Home
Search for:
Search Only:
Total: 16 results found.

Some additional information

... wanted to do 6 doses but the FDA did not allow that for safety reasons. The Faustman lab and the MGH are experienced at dosing trials and although the protocols are approved within Harvard it is too ...

The FDA and You - Up Close and Personal

... to see what the FDA will do about Phase 2 of Dr. Denise Faustman’s BCG trials.  That is, whether they will be as unreasonably restrictive as they were in Phase 1.                ...

Newsletter # 6 WAITING FOR FDA APPROVAL

... Is there any other reason why the FDA shouldn’t allow Faustman anything and everything she needs in these trials?  Is there any actual, scientific, logical, factual or otherwise really apparent ...

Occupy Corporatism and diabetes type 1

... it won't help people who already have Diabetes type 1. Reference, http://jdca2025.wordpress.com/2012/01/19/jdca-report-type-1-human-clinical-trials-further-disconnect/ You can read the actual ...

Faustman Research Phase 1 BCG abstract

...  and even reversal of advanced type 1 diabetes. Larger trials are necessary to extend these results and identify the most effective doses and frequency of BCG treatment. Category Clinical Therapeutics/Ne ...

Multiple Sclerosis MS and Diabetes Type 1

... in her legs, there isn’t a problem. So it’s perplexing that clinical trials destined to take years are required before MS patients receive similar treatment. Behind the scenes, people with MS were communicating ...

The most promising research in healing diabetes type 1

... first trials, big media is really quiet about this research.  It sounds strange, but the reason is this:  pharmaceutical groups focus their research on expensive treatment and not a cure for ...